These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2557568

  • 1. Ligand-binding characteristics of [3H]QNB, [3H]prazosin, [3H]rauwolscine, [3H]TCP and [3H]nitrendipine to cerebral cortical and hippocampal membranes of senescence accelerated mouse.
    Kitamura Y, Zhao XH, Ohnuki T, Nomura Y.
    Neurosci Lett; 1989 Dec 04; 106(3):334-8. PubMed ID: 2557568
    [Abstract] [Full Text] [Related]

  • 2. Effects of deoxyribonuclease I and neuraminidase treatments on the specific binding of 3H-prazosin and 3H-quinuclidinyl benzilate (3H-QNB) to alpha-adrenergic and muscarinic receptors in rat myocardial membranes.
    Nagatomo T, Tsuchihashi H, Imai S.
    Jpn J Pharmacol; 1986 May 04; 41(1):135-8. PubMed ID: 3016391
    [Abstract] [Full Text] [Related]

  • 3. Lack of specific (3H) prazosin binding sites in dog and rabbit cerebral arteries.
    Ferron PM, Banner W, Duckles SP.
    Life Sci; 1984 Nov 19; 35(21):2169-76. PubMed ID: 6092817
    [Abstract] [Full Text] [Related]

  • 4. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
    Hussain JF, Kendall DA, Wilson VG.
    Br J Pharmacol; 1993 Jul 19; 109(3):831-7. PubMed ID: 8102937
    [Abstract] [Full Text] [Related]

  • 5. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1986 May 19; 237(2):411-8. PubMed ID: 3754580
    [Abstract] [Full Text] [Related]

  • 6. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1986 May 19; 237(2):419-27. PubMed ID: 3754581
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interaction of metals with muscarinic cholinoceptor and adrenoceptor binding, and agonist-stimulated inositol phospholipid hydrolysis in rat brain.
    Rajanna B, Chetty CS, Rajanna S, Hall E, Fail S, Yallapragada PR.
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1997 Feb 19; 116(2):111-6. PubMed ID: 9134697
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of bifemelane hydrochloride, a brain function improver, on muscarinic receptors in the CNS of senescence-accelerated mouse.
    Kitamura Y, Ohnuki T, Nomura Y.
    Jpn J Pharmacol; 1991 Jun 19; 56(2):231-5. PubMed ID: 1881003
    [Abstract] [Full Text] [Related]

  • 14. Characterization of neurotransmitter receptors in the rat hippocampal formation.
    Dooley DJ, Bittiger H.
    J Neurochem; 1982 Jun 19; 38(6):1621-6. PubMed ID: 6122720
    [Abstract] [Full Text] [Related]

  • 15. Cholinergic muscarinic receptor in synaptosomal membranes. Heterogeneity of binding sites for L-[3H]quinuclidinyl benzilate.
    Aguilar JS, Salas PJ, De Robertis E.
    Mol Pharmacol; 1982 Sep 19; 22(2):304-9. PubMed ID: 7144732
    [No Abstract] [Full Text] [Related]

  • 16. Autoradiographic localization of alpha-adrenoceptors, muscarinic acetylcholine receptors and opiate receptors in the heart.
    Dashwood MR, Spyer KM.
    Eur J Pharmacol; 1986 Aug 15; 127(3):279-82. PubMed ID: 3019733
    [Abstract] [Full Text] [Related]

  • 17. Developmental changes in beta-adrenoceptors, muscarinic cholinoceptors and Ca2+ channels in rat ventricular muscles.
    Kojima M, Ishima T, Taniguchi N, Kimura K, Sada H, Sperelakis N.
    Br J Pharmacol; 1990 Feb 15; 99(2):334-9. PubMed ID: 2158375
    [Abstract] [Full Text] [Related]

  • 18. Verapamil competitively inhibits alpha 1-adrenergic and muscarinic but not beta-adrenergic receptors in rat myocardium.
    Karliner JS, Motulsky HJ, Dunlap J, Brown JH, Insel PA.
    J Cardiovasc Pharmacol; 1982 Feb 15; 4(3):515-20. PubMed ID: 6177951
    [Abstract] [Full Text] [Related]

  • 19. Muscarinic cholinergic receptors in human foetal brain: characterization and ontogeny of [3H]quinuclidinyl benzilate binding sites in frontal cortex.
    Ravikumar BV, Sastry PS.
    J Neurochem; 1985 Jan 15; 44(1):240-6. PubMed ID: 3964831
    [Abstract] [Full Text] [Related]

  • 20. Ligand binding characteristics of [3H] dihydroalprenolol in cerebral cortical membranes of young and old senescence-accelerated mouse.
    Suh YH, Lee IS, Kim SS, Choi W, Park CW, Chung MH, Lim JK.
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Mar 15; 104(3):423-6. PubMed ID: 8103434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.